Teva Pharmaceutical
-
New York AG: Teva USA’s parent company shouldn’t be allowed to escape opioid liability
Without the parent company, there’s concern Teva won’t be able to pay billions in reward to NY state.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Four big pharma companies team up in AI initiative focused on drug R&D
A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.
-
Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
-
Teva CEO stands down during troubled times
Teva Pharmaceuticals’ CEO Erez Vigodman stepped down on Monday — “effective immediately” — after a tumultuous few years at the helm.